导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.87% | 751/4773 |
| 近一周 | 0.30% | 651/5465 |
| 近一月 | -6.58% | 4234/5421 |
| 近一季 | -12.32% | 4028/5231 |
| 近半年 | 11.66% | 517/4920 |
| 近一年 | 15.75% | 769/4394 |
| 近两年 | 172.31% | 150/2954 |
| 近三年 | 123.22% | 76/2253 |
| 成立以来 | 151.28% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.46% 4152/4961 |
54.78% 498/5312 |
- - |
- - |
| 2025 | 68.28% 140/4813 |
5.09% 832/3635 |
1.46% 2322/4076 |
58.83% 140/4524 |
-0.63% 2572/4813 |
| 2024 | 19.86% 499/3463 |
-1.90% 1294/2808 |
-3.06% 1294/3014 |
15.08% 1817/3129 |
9.52% 324/3463 |
| 2023 | 11.50% 71/2656 |
38.30% 39/2280 |
-2.59% 614/2385 |
-14.45% 2186/2515 |
-3.25% 637/2655 |
| 2022 | -34.00% 1710/2207 |
-19.91% 1505/1919 |
-3.86% 1841/2016 |
-20.02% 1829/2113 |
7.18% 325/2208 |
| 2021 | 14.04% 344/1822 |
-5.51% 930/1255 |
16.15% 209/1330 |
-6.69% 979/1466 |
11.36% 87/1822 |
| 2020 | 26.47% 605/1250 |
3.42% 120/1028 |
20.56% 268/1067 |
1.90% 1018/1164 |
-0.46% 1075/1184 |
| 2019 | - - |
- - |
- - |
- - |
6.90% 523/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 平安人工智能ETF VS. 长安沪深300非周期A(740101) |